Author:
Hindié Elif,Ureña-Torres Pablo A.,Taïeb David
Publisher
Springer International Publishing
Reference77 articles.
1. Ureña-Torres P, Vervloet M, Mazzaferro S, et al. Novel insights into parathyroid hormone: report of the parathyroid day in chronic kidney disease. Clin Kidney J. 2018;11:1–12.
2. Floege J, Kim J, Ireland E, et al. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transpl. 2011;26(6):1948–55.
3. Quarles LD. Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease. Exp Cell Res. 2012;318(9):1040–8.
4. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK. Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol. 2001;12(10):2131–8.
5. Tentori F, Blayney MJ, Albert JM, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis. 2008;52(3):519–30.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Dual-tracer 99mTc-sestamibi/ 123I imaging in primary hyperparathyroidism;The Quarterly Journal of Nuclear Medicine and Molecular Imaging;2023-05
2. An essential practice summary of the new EANM guidelines for parathyroid imaging;The Quarterly Journal of Nuclear Medicine and Molecular Imaging;2022-05
3. The EANM practice guidelines for parathyroid imaging;European Journal of Nuclear Medicine and Molecular Imaging;2021-04-10